Logo image of ADN1.DE

ADESSO SE (ADN1.DE) Stock Fundamental Analysis

FRA:ADN1 - Deutsche Boerse Ag - DE000A0Z23Q5 - Common Stock - Currency: EUR

89.2  -2.1 (-2.3%)

Fundamental Rating

4

Overall ADN1 gets a fundamental rating of 4 out of 10. We evaluated ADN1 against 70 industry peers in the IT Services industry. While ADN1 seems to be doing ok healthwise, there are quite some concerns on its profitability. ADN1 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ADN1 was profitable.
ADN1 had a positive operating cash flow in the past year.
ADN1 had positive earnings in each of the past 5 years.
In the past 5 years ADN1 always reported a positive cash flow from operatings.
ADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

1.2 Ratios

ADN1's Return On Assets of 0.88% is on the low side compared to the rest of the industry. ADN1 is outperformed by 61.33% of its industry peers.
The Return On Equity of ADN1 (3.43%) is worse than 60.00% of its industry peers.
ADN1's Return On Invested Capital of 5.07% is on the low side compared to the rest of the industry. ADN1 is outperformed by 64.00% of its industry peers.
ADN1 had an Average Return On Invested Capital over the past 3 years of 4.44%. This is significantly below the industry average of 11.01%.
The last Return On Invested Capital (5.07%) for ADN1 is above the 3 year average (4.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.88%
ROE 3.43%
ROIC 5.07%
ROA(3y)4.43%
ROA(5y)4.87%
ROE(3y)13.62%
ROE(5y)16.03%
ROIC(3y)4.44%
ROIC(5y)5.46%
ADN1.DE Yearly ROA, ROE, ROICADN1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 0.37%, ADN1 is doing worse than 61.33% of the companies in the same industry.
In the last couple of years the Profit Margin of ADN1 has declined.
Looking at the Operating Margin, with a value of 2.41%, ADN1 is doing worse than 69.33% of the companies in the same industry.
In the last couple of years the Operating Margin of ADN1 has declined.
With a decent Gross Margin value of 86.64%, ADN1 is doing good in the industry, outperforming 77.33% of the companies in the same industry.
ADN1's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.41%
PM (TTM) 0.37%
GM 86.64%
OM growth 3Y-35.22%
OM growth 5Y-20.31%
PM growth 3Y-58.69%
PM growth 5Y-40.36%
GM growth 3Y-0.82%
GM growth 5Y-0.69%
ADN1.DE Yearly Profit, Operating, Gross MarginsADN1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN1 is destroying value.
ADN1 has about the same amout of shares outstanding than it did 1 year ago.
ADN1 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ADN1 is higher compared to a year ago.
ADN1.DE Yearly Shares OutstandingADN1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ADN1.DE Yearly Total Debt VS Total AssetsADN1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

ADN1 has an Altman-Z score of 3.42. This indicates that ADN1 is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ADN1 (3.42) is better than 76.00% of its industry peers.
The Debt to FCF ratio of ADN1 is 3.27, which is a good value as it means it would take ADN1, 3.27 years of fcf income to pay off all of its debts.
ADN1's Debt to FCF ratio of 3.27 is in line compared to the rest of the industry. ADN1 outperforms 58.67% of its industry peers.
A Debt/Equity ratio of 1.01 is on the high side and indicates that ADN1 has dependencies on debt financing.
ADN1's Debt to Equity ratio of 1.01 is on the low side compared to the rest of the industry. ADN1 is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 3.27
Altman-Z 3.42
ROIC/WACC0.92
WACC5.53%
ADN1.DE Yearly LT Debt VS Equity VS FCFADN1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.02 indicates that ADN1 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, ADN1 is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
A Quick Ratio of 1.02 indicates that ADN1 should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.02, ADN1 is in line with its industry, outperforming 44.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
ADN1.DE Yearly Current Assets VS Current LiabilitesADN1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

6

3. Growth

3.1 Past

ADN1 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.43%.
The earnings per share for ADN1 have been decreasing by -26.37% on average. This is quite bad
ADN1 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.90%.
Measured over the past years, ADN1 shows a very strong growth in Revenue. The Revenue has been growing by 24.77% on average per year.
EPS 1Y (TTM)-64.43%
EPS 3Y-47.47%
EPS 5Y-26.37%
EPS Q2Q%98.31%
Revenue 1Y (TTM)16.9%
Revenue growth 3Y29.47%
Revenue growth 5Y24.77%
Sales Q2Q%14.92%

3.2 Future

ADN1 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.56% yearly.
ADN1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.32% yearly.
EPS Next Y42.48%
EPS Next 2Y64.25%
EPS Next 3Y58.85%
EPS Next 5Y42.56%
Revenue Next Year17.2%
Revenue Next 2Y14.2%
Revenue Next 3Y13.18%
Revenue Next 5Y13.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ADN1.DE Yearly Revenue VS EstimatesADN1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
ADN1.DE Yearly EPS VS EstimatesADN1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 84.95, the valuation of ADN1 can be described as expensive.
ADN1's Price/Earnings ratio is a bit more expensive when compared to the industry. ADN1 is more expensive than 61.33% of the companies in the same industry.
ADN1's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.35.
The Price/Forward Earnings ratio is 20.23, which indicates a rather expensive current valuation of ADN1.
ADN1's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ADN1 is around the same levels.
Industry RankSector Rank
PE 84.95
Fwd PE 20.23
ADN1.DE Price Earnings VS Forward Price EarningsADN1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ADN1 is valued a bit cheaper than the industry average as 64.00% of the companies are valued more expensively.
ADN1's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ADN1 is cheaper than 88.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.67
EV/EBITDA 7.91
ADN1.DE Per share dataADN1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ADN1 does not grow enough to justify the current Price/Earnings ratio.
ADN1's earnings are expected to grow with 58.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)2
PEG (5Y)N/A
EPS Next 2Y64.25%
EPS Next 3Y58.85%

3

5. Dividend

5.1 Amount

ADN1 has a yearly dividend return of 0.82%, which is pretty low.
ADN1's Dividend Yield is comparable with the industry average which is at 4.29.
With a Dividend Yield of 0.82, ADN1 pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 0.82%

5.2 History

The dividend of ADN1 is nicely growing with an annual growth rate of 14.71%!
Dividend Growth(5Y)14.71%
Div Incr Years5
Div Non Decr Years5
ADN1.DE Yearly Dividends per shareADN1.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

ADN1 pays out 141.72% of its income as dividend. This is not a sustainable payout ratio.
ADN1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP141.72%
EPS Next 2Y64.25%
EPS Next 3Y58.85%
ADN1.DE Yearly Income VS Free CF VS DividendADN1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
ADN1.DE Dividend Payout.ADN1.DE Dividend Payout, showing the Payout Ratio.ADN1.DE Dividend Payout.PayoutRetained Earnings

ADESSO SE

FRA:ADN1 (3/7/2025, 7:00:00 PM)

89.2

-2.1 (-2.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-14 2024-11-14
Earnings (Next)03-27 2025-03-27/amc
Inst Owners17.52%
Inst Owner ChangeN/A
Ins Owners51.92%
Ins Owner ChangeN/A
Market Cap581.58M
Analysts80
Price Target125.75 (40.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.82%
Yearly Dividend0.81
Dividend Growth(5Y)14.71%
DP141.72%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.12%
PT rev (3m)5.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 84.95
Fwd PE 20.23
P/S 0.31
P/FCF 5.67
P/OCF 4.32
P/B 2.87
P/tB 9.06
EV/EBITDA 7.91
EPS(TTM)1.05
EY1.18%
EPS(NY)4.41
Fwd EY4.94%
FCF(TTM)15.72
FCFY17.62%
OCF(TTM)20.64
OCFY23.13%
SpS286.51
BVpS31.05
TBVpS9.85
PEG (NY)2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.88%
ROE 3.43%
ROCE 10.52%
ROIC 5.07%
ROICexc 5.66%
ROICexgc 8.87%
OM 2.41%
PM (TTM) 0.37%
GM 86.64%
FCFM 5.49%
ROA(3y)4.43%
ROA(5y)4.87%
ROE(3y)13.62%
ROE(5y)16.03%
ROIC(3y)4.44%
ROIC(5y)5.46%
ROICexc(3y)6.02%
ROICexc(5y)7.27%
ROICexgc(3y)9.54%
ROICexgc(5y)12.32%
ROCE(3y)9.22%
ROCE(5y)11.32%
ROICexcg growth 3Y-40.62%
ROICexcg growth 5Y-48.47%
ROICexc growth 3Y-36.44%
ROICexc growth 5Y-28.67%
OM growth 3Y-35.22%
OM growth 5Y-20.31%
PM growth 3Y-58.69%
PM growth 5Y-40.36%
GM growth 3Y-0.82%
GM growth 5Y-0.69%
F-Score5
Asset Turnover2.36
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 3.27
Debt/EBITDA 1.86
Cap/Depr 49.48%
Cap/Sales 1.72%
Interest Coverage 3.5
Cash Conversion 122.53%
Profit Quality 1475.03%
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 3.42
F-Score5
WACC5.53%
ROIC/WACC0.92
Cap/Depr(3y)54.67%
Cap/Depr(5y)51.19%
Cap/Sales(3y)2.8%
Cap/Sales(5y)2.6%
Profit Quality(3y)477.04%
Profit Quality(5y)350.42%
High Growth Momentum
Growth
EPS 1Y (TTM)-64.43%
EPS 3Y-47.47%
EPS 5Y-26.37%
EPS Q2Q%98.31%
EPS Next Y42.48%
EPS Next 2Y64.25%
EPS Next 3Y58.85%
EPS Next 5Y42.56%
Revenue 1Y (TTM)16.9%
Revenue growth 3Y29.47%
Revenue growth 5Y24.77%
Sales Q2Q%14.92%
Revenue Next Year17.2%
Revenue Next 2Y14.2%
Revenue Next 3Y13.18%
Revenue Next 5Y13.32%
EBIT growth 1Y-7.92%
EBIT growth 3Y-16.13%
EBIT growth 5Y-0.57%
EBIT Next Year273.29%
EBIT Next 3Y76.67%
EBIT Next 5Y45.94%
FCF growth 1Y726.09%
FCF growth 3Y-7.75%
FCF growth 5Y36.3%
OCF growth 1Y272.41%
OCF growth 3Y5.77%
OCF growth 5Y33.72%